TAU Therapeutics LLC
A New Way of Treating Cancer
 |
Home | |
|
Checkpoint Therapy | |
|
The Science | |
|
Drug Development | |
|
Contact the Team | |
|---|
| NAVIGATE: |
|
|---|
|
Contact Information: Andrew J. Krouse CEO and Founder TAU Therapeutics LLC 3311 Turnberry Circle Charlottesville, VA 22911 434-974-6969 434-989-6299 (c) krouse@tautherapeutics.com |
|
Andrew J. Krouse Chairman and Founder. Fifteen years senior university leadership including Vice President of the Darden School of Business. Consultant. Former Goldman Sachs, NYC. Graduate Maryland Business School; Master’s Degree, Georgetown University; The Executive Program, The Darden School of Business, University of Virginia. Selected to participate in the Washington Metro-area Mindshare 2005 for the hottest emerging companies in the region. |
|
Dr. Lloyd Gray, MD Founder and Vice President, Scientific Discover: Associate Professor, Pathology and Director of Clinical Immunology, Department of Pathology, University of Virginia Medical Center. Inventor on several patents including compounds and on the discovery of the Cytostatic Checkpoint Therapy. Medical Degree, University of Connecticut; Former Research Fellow at Sloan Kettering and Washington University. |
|
Dr. Timothy Macdonald Founder and Vice President, Drug Discovery; Professor and immediate past Chairman of Chemistry, University of Virginia. Patent co-holder on compounds. Founder of Adenosine Therapeutics LLC, AlGlutamine LLC, IDR Therapeutics LLC and consultant to pharmaceutical companies. PHD Columbia University. |